Skip to main content

Table 1 Background and treatments of the 47 patients

From: The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer

 

dCRT

ESD-CRT

p -value

Patients

n = 31

n = 16

 

Age (median)

33–80 (68)

42–77 (65)

0.31

Gender (male:female)

25:6

15:1

0.229

Observation period (median)

2.5–93.1 (34.2)

6.5–78.4 (39.0)

0.682

Location

  

0.959

  Cervical

2

0

 

  Upper thoracic

1

1

 

  Middle thoracic

18

10

 

Lower thoracic

10

5

 

Tumor depth

   
 

M3: 3

M3: 2

0.297

 

SM1: 15

SM1: 4

 
 

SM2: 13

SM2: 10

 

Radiation field

   

  Long T

11

15

0.0001

  Short T

3

1

 

  Local

17

0

 

Radiation dose (Gy)

   

  40 (−44)

0

10

0.00001

  54

1

0

 

  60

13

6

 

  60<

17

0

 

Chemotherapy

   

  Standard-dose FP

12

10

0.046

  Low-dose FP

6

4

 

  Low-dose 5-FU

9

2

 

  Others

4

0

 
  1. Abbreviations: dCRT definitive chemoradiotherapy, ESD-CRT endoscopic submucosal dissection + chemoradiotherapy.